Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T08:21:28.773Z Has data issue: false hasContentIssue false
  • English
  • Français

Metabolic Balance Studies on the Effect of Lithium Salts in Manic-Depressive Psychosis

Published online by Cambridge University Press:  29 January 2018

R. McDonald ,
G. A. Dransfield ,
R. P. Hullin  and
J. C. Swinscoe
R. McDonald
Affiliation:
High Royds Hospital, Menston, Ilkley, Yorkshire
G. A. Dransfield
Affiliation:
High Royds Hospital, Menston, Ilkley, Yorkshire
R. P. Hullin
Affiliation:
Department of Biochemistry University of Leeds
J. C. Swinscoe
Affiliation:
Department of Biochemistry University of Leeds
Get access Rights & Permissions [Opens in a new window]

Extract

The specific therapeutic effect of lithium salts in the treatment of the manic phases of manicdepressive psychosis was first reported by Cade (1949) and has been confirmed in a number of studies since (Schou, Juel-Nielson, Strömgren and Voldby, 1954; Maggs, 1963; Hartigan, 1963). In view of the claims made by Baastrup (1964) and more recendy by Baastrup and Schou (1967) that lithium also has a prophylactic action against both manic and depressive phases of manic-depressive psychosis it is likely that lithium salts will be used increasingly by psychiatrists.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 114 , Issue 517 , December 1968 , pp. 1561 - 1573
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baastrup, P. C. (1964). “The use of lithium in manicdepressive psychosis.” Compreh. Psychiat., 5, 396–408.CrossRefGoogle Scholar
Baastrup, P. C. and Schou, M. (1967). “Lithium as a prophylactic agent. Its effect against recurrent depression and manic-depressive psychosis.” Arch. gen. Psychiat., 16, 162–172.CrossRefGoogle Scholar
Cade, J. F. J. (1949). “Lithium salts in the treatment of psychotic excitement.” Med. J. Aust., 36 (II), 349–352.Google Scholar
Coppen, A. J., Malleson, A., and Shaw, D. M. (1965). “Effects of lithium carbonate on electrolyte distribution in man.” Lancet, i, 682–683.Google Scholar
Hamilton, M. (1960). “A rating scale for depression.” J. Neurol. Neurosurg. Psychiat., 23, 56–62.Google Scholar
Hartigan, G. P. (1963). “The use of lithium salts in affective disorders.” Brit. J. Psychiat., 109, 810–814.Google Scholar
Hullin, R. P., Bailey, A. D., McDonald, R., Drans-Ffield, G. A., and Milne, H. B. (1967). “Variations in 11-hydroxycorticosteroids in depression and manic-depressive psychosis.” Brit. J. Psychiat., 113, 593–600.Google Scholar
Maggs, R. (1963). “Treatment of manic illness with lithium carbonate.” Brit. J. Psychiat., 109, 56–65.Google Scholar
Margerison, J. H., Anderson, W. Mc., Dawson, J., and Lettich, E. (1962). “The relationship between sodium metabolism, verbal output and the E.E.G. in 21 depressives.” Electroenceph. clin. Neurophysiol., 14, 853–857.CrossRefGoogle Scholar
Schales, O., and Schales, S. S. (1941). “A simple and accurate method for the determination of chloride in biological fluids.” J. biol. Chem., 140, 879–884.Google Scholar
Schou, M. (1957). “Biology and pharmacology of the lithium ion.” Pharmacol. Rev., 9, 17–58.Google Scholar
Schou, M. (1958). “Lithium studies. 3. Distribution between serum and tissues.” Acta Pharmacol. (KBH), 15, 115–124.CrossRefGoogle Scholar
Schou, M. Juel-Nielson, N., Strömgren, E., and Voldby, H. (1954). “The treatment of manic psychoses by the administration of lithium salts.” J. Neurol. Neurosurg. Psychiat., 17, 250–260.Google Scholar
Woodbury, D. M. (1958). “Relation between the adrenal cortex and the central nervous system.” Pharmacol. Rev., 10, 275–357.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.